Your browser doesn't support javascript.
loading
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Mok, Tze How; Nihat, Akin; Majbour, Nour; Sequeira, Danielle; Holm-Mercer, Leah; Coysh, Thomas; Darwent, Lee; Batchelor, Mark; Groveman, Bradley R; Orr, Christina D; Hughson, Andrew G; Heslegrave, Amanda; Laban, Rhiannon; Veleva, Elena; Paterson, Ross W; Keshavan, Ashvini; Schott, Jonathan M; Swift, Imogen J; Heller, Carolin; Rohrer, Jonathan D; Gerhard, Alexander; Butler, Christopher; Rowe, James B; Masellis, Mario; Chapman, Miles; Lunn, Michael P; Bieschke, Jan; Jackson, Graham S; Zetterberg, Henrik; Caughey, Byron; Rudge, Peter; Collinge, John; Mead, Simon.
Afiliação
  • Mok TH; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Nihat A; NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK.
  • Majbour N; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Sequeira D; NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK.
  • Holm-Mercer L; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Coysh T; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Darwent L; NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK.
  • Batchelor M; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Groveman BR; NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK.
  • Orr CD; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Hughson AG; NHS National Prion Clinic, National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK.
  • Heslegrave A; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Laban R; Medical Research Council Prion Unit at University College London, UCL Institute of Prion Diseases, London W1W 7FF, UK.
  • Veleva E; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
  • Paterson RW; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
  • Keshavan A; Laboratory of Persistent Viral Diseases, Rocky Mountain Laboratories, National Institute for Allergy and Infectious Diseases, National Institutes of Health, Hamilton, MT 59840, USA.
  • Schott JM; Department of Neurodegenerative Disease, UCL Institute of Neurology, Queen Square, London WC1N 3BG, UK.
  • Swift IJ; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Heller C; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Rohrer JD; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Gerhard A; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Butler C; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Rowe JB; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Masellis M; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Chapman M; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Lunn MP; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Bieschke J; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Jackson GS; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Zetterberg H; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Caughey B; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Rudge P; United Kingdom Dementia Research Institute at University College London, London WC1E 6BT, UK.
  • Collinge J; Dementia Research Centre, Department of Neurodegenerative Disease, University College London Queen Square Institute of Neurology, London WC1N 3AR, UK.
  • Mead S; Division of Neuroscience and Experimental Psychology, Wolfson Molecular Imaging Centre, University of Manchester, Manchester M13 9PL, UK.
Brain ; 146(6): 2570-2583, 2023 06 01.
Article em En | MEDLINE | ID: mdl-36975162

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Príons / Síndrome de Creutzfeldt-Jakob / Doenças Priônicas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Príons / Síndrome de Creutzfeldt-Jakob / Doenças Priônicas Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Brain Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Reino Unido